Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
T2 Biosystems, Inc. (TTOO) had Return on Equity of 178.62% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$7.19M |
|
$-50.08M |
|
$15.36M |
|
$-8.17M |
|
$56.86M |
|
$-49.66M |
|
$-0.41M |
|
$-50.08M |
|
$-50.08M |
|
$-50.08M |
|
$-50.08M |
|
$-50.08M |
|
$-50.08M |
|
$-49.66M |
|
$-48.80M |
|
2.61M |
|
2.61M |
|
$-19.19 |
|
$-19.19 |
|
| Balance Sheet Financials | |
$25.19M |
|
$1.66M |
|
$9.61M |
|
$34.80M |
|
$56.15M |
|
-- |
|
$6.68M |
|
$62.83M |
|
$-28.04M |
|
$-28.04M |
|
$-28.04M |
|
4.06M |
|
| Cash Flow Statement Financials | |
$-48.14M |
|
$-0.19M |
|
$52.69M |
|
$11.88M |
|
$16.24M |
|
$4.36M |
|
$4.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.45 |
|
-- |
|
-- |
|
-- |
|
-1.47 |
|
-113.58% |
|
-690.45% |
|
-690.45% |
|
-678.51% |
|
-696.19% |
|
-696.19% |
|
$-48.33M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
3.19 |
|
5.07 |
|
72.06 |
|
|
Return on Equity |
178.62% |
178.62% |
|
-143.91% |
|
178.62% |
|
$-6.91 |
|
$-18.52 |
|
$-18.44 |
|